If you've been curious about weight loss medications but feel overwhelmed by all the options, you're not alone. With so many ...

GLP-1 drugs like Ozempic have become massively popular for their slimming side effects, but understanding of their effects is ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance (PASI 100) and ≥10% weight loss In ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who've struggled to ...

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...

If middle-class Americans lose their jobs to AI, that could mean fewer cash sales of weight-loss drugs like Zepbound.

Adverse events in participants treated with concomitant administration of Taltz and Zepbound were generally mild to moderate, and the types of adverse events were consistent with the known safety ...